F. Schneider

发表

Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia

H. Leonhardt, K. Spiekermann, S. Bohlander, 2011, Leukemia.

AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia

W. Hiddemann, S. Bohlander, C. Buske, 2007, Leukemia.

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.

E. Hoster, W. Hiddemann, K. Metzeler, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia

W. Hiddemann, S. Bohlander, K. Spiekermann, 2008, British journal of haematology.

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

E. Hoster, W. Hiddemann, S. Bohlander, 2012, Annals of Hematology.

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes

Wolfgang Hiddemann, Tobias Herold, Karsten Spiekermann, 2012, Haematologica.

GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.

E. Hoster, W. Hiddemann, S. Bohlander, 2012, Blood.

Running title : GATA 2 mutations in bi CEBPA AML 1 GATA 2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia *

E. Hoster, W. Hiddemann, S. Bohlander, 2012 .

The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype.

E. Hoster, W. Hiddemann, S. Bohlander, 2012, Blood.

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)

E. Hoster, W. Hiddemann, S. Bohlander, 2011, Annals of Hematology.

Brief Report Results and Discussion

E. Hoster, W. Hiddemann, S. Bohlander, 2022 .

Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML

E. Hoster, W. Hiddemann, S. Bohlander, 2008 .

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

E. Hoster, W. Hiddemann, S. Bohlander, 2012, Annals of Hematology.

The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype.

E. Hoster, W. Hiddemann, S. Bohlander, 2012, Blood.

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).

E. Hoster, J. Braess, M. Sauerland, 2006, Blood.